Pope, L
[DOI] [PMC free article] [PubMed] [Google Scholar] 61.Sung J.H., Jo Y.S., Kim S.J., Ryu J.S., Kim M.C., Ko H.J., et al
The compound is often discussed in relation to mitochondria, the structures responsible for generating ATP, the molecule that powers nearly every biological process
Developed by Novo Nordisk, semaglutide has already received FDA approval for controlling blood sugar, reducing cardiovascular risks in T2D patients, and treating obesity in individuals aged 12 and older [7, 8]
With 12% of Americans using GLP-1s a figure thats only expected to grow as the medications become more available and affordable the food and beverage industry has begun to feel the impact, which is hitting some categories harder than others